Cover: An Economic Evaluation of a School-Based Sexually Transmitted Disease Screening Program

An Economic Evaluation of a School-Based Sexually Transmitted Disease Screening Program

Published in: Sexually Transmitted Diseases, v. 29, no. 12, Dec. 2002, p. 737-745

Posted on 2002

by Li Yan Wang, Gale R. Burstein, Deborah A. Cohen

BACKGROUND: A school-based sexually transmitted disease (STD) screening program was implemented in eight New Orleans public high schools to detect chlamydia and gonorrhea. GOAL: The goal was to assess the incremental cost-effectiveness of replacing non-school-based screening with the school-based screening program. STUDY DESIGN: A decision-analysis model was constructed to compare costs and cases of expected pelvic inflammatory disease (PID) in the school-based screening scenario versus a non-school-based screening scenario. Cost-effectiveness was quantified and measured as cost per case of PID prevented. RESULTS: Under base-case assumptions, at an intervention cost of $86,449, the school screening program prevented an estimated 38 cases of PID, as well as $119,866 in treatment costs for PID and its sequelae, resulting in savings of $1524 per case of PID prevented. Results remained cost-saving over a reasonable range of model parameter estimates. CONCLUSIONS: The New Orleans school-based chlamydia screening program was cost-effective and cost-saving and could be cost-effective in other settings. School-based screening programs of this type are likely to be a cost-effective use of public funds and can reduce the burden of STDs among adolescents.

This report is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.